Urine
13
0
1
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (13)
Determination of the Effectiveness of Two Different Noninvasive Stimulation Methods in Urine Collection in Infants
S100A8 in Serum and Urine as a New Biomarker in Lupus Nephritis
The Effect of a Zero Tolerance Program (SToP) on Child's Urine Cotinine Level According to Exposure Feedback
Risk Stratification of COVID-19 Using Urine Biomarkers
Effect of Preventive Education on Reducing Urinary Bisphenol-A Levels in Adolescents
Evaluation Protocols for Isolation of Analytes From Urine for Future Oncology Applications
Investigation of Urinary Biomarkers for the Detection of Prostate Cancer
Investigation of Urinary Biomarkers for the Detection of Breast Cancer
Urine-DNA Biomarkers in Detecting Bladder Cancer
CASUS: Validation for Detection of Precursor Lesions
COVID-19 (SARS-CoV-2) in Urine and Semen
CASUS: Improved and Quality Assured Collection of First-void Urine
Lipid Peroxidation in Workers Exposed to Al,Ga,In,As,and Sb in Optoelectronic Industry